Saint Pierre and Miquelon

Reimbursed Care Access

Saint Pierre and Miquelon is an overseas collectivity of France and is subject to French national drug and medical regulation. Therapeutic access to psychedelic compounds is limited: esketamine (Spravato) is an authorized, conditionally reimbursed treatment for specific resistant depression indications under HAS/ANSM conditions, ketamine is available in medical settings (anesthesia and hospital-controlled use) but is tightly controlled as a stupéfiant; the other listed classical psychedelics and entheogens remain unlawful outside of authorised clinical research.